Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 101

Sort by

Sort Order Select

Journal Articles

High Progression-Free Survival with Low Relapse Rates after Double-Unit Cord Blood Transplantation in Patients with High-Risk AML

Ioannis Politikos, Warren B Fingrut, Samantha Brown, Stephanie Chinapen, Sean Quach, Parastoo B. Dahi, Boglarka Gyurkocza, Ann A. Jakubowski, Esperanza B. Papadopoulos, Doris M. Ponce, Roni Tamari, Miguel-Angel Perales, Andromachi Scaradavou, Juliet N Barker

Blood (2023) 142 (Supplement 1): 2209.

https://doi.org/10.1182/blood-2023-190836

Published: 2023

Journal Articles

Optimized Double-Unit Cord Blood Transplantation Mitigates Transplant-Related Mortality Resulting in High Progression-Free Survival in Adults with Hematologic Malignancies

Ioannis Politikos, Sean M. Devlin, Stephanie Chinapen, Sean Quach, Parastoo B. Dahi, Boglarka Gyurkocza, Ann A. Jakubowski, Esperanza B. Papadopoulos, Doris M. Ponce, Roni Tamari, Andromachi Scaradavou, Juliet N Barker

Blood (2023) 142 (Supplement 1): 4916.

https://doi.org/10.1182/blood-2023-190528

Published: 2023

Journal Articles

Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Leukemia

Shlomo Elias, Moneeza Walji, Samantha Brown, Sean M. Devlin, Esperanza B. Papadopoulos, Ann A Jakubowski, Doris M Ponce, James W. Young, Sergio A Giralt, Miguel-Angel Perales, Brian C. Shaffer, Parastoo B. Dahi, Richard J. Lin, Christina Cho, Roni Tamari, Melody Smith, Boglarka Gyurkocza

Blood (2022) 140 (Supplement 1): 10627–10628.

https://doi.org/10.1182/blood-2022-170088

Published: 2022

Journal Articles

Prospective Analysis to Determine Barriers to Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed and Relapsed Acute Leukemia

Blood (2022) 140 (Supplement 1): 2137–2139.

https://doi.org/10.1182/blood-2022-157193

Published: 2022

Journal Articles

Racial Disparities in Access to Alternative Donor Allografts Persist in the Era of "Donors for All"

Warren Fingrut, Ioannis Politikos, Eric Davis, Stephanie Chinapen, Kristine Naputo, Christina Cho, Sergio A Giralt, Boglarka Gyurkocza, Ann A Jakubowski, Esperanza B Papadopoulos, Miguel-Angel Perales, Doris M Ponce, Andromachi Scaradavou, Brian C Shaffer, Juliet N Barker

Blood (2021) 138 (Supplement 1): 423.

https://doi.org/10.1182/blood-2021-147329

Published: 2021

Journal Articles

Clinical Outcomes of Acute Myeloid Leukemia Patients Bridged to Allogeneic Stem Cell Transplant By Venetoclax Combination Therapy

Blood (2020) 136 (Supplement 1): 16–17.

https://doi.org/10.1182/blood-2020-137749

Published: 2020

Journal Articles

Rabbit Anti-Thymocyte Globulin Exposure (rATG) in CD34+ Selected Hematopoietic Cell Transplantation and Its Impact on Immune Reconstitution and Outcomes in Children and Adults

Blood (2020) 136 (Supplement 1): 30–31.

https://doi.org/10.1182/blood-2020-136341

Published: 2020

Journal Articles

A High Degree of Engrafting Unit-Recipient HLA-Allele Mismatch Is Not Associated with an Increased Risk of Transplant-Related Mortality (TRM) or Inferior Progression-Free Survival (PFS) after Double Unit Cord Blood (CB) Transplantation (dCBT) in Adults with Hematologic Malignancies

Blood (2018) 132 (Supplement 1): 3470.

https://doi.org/10.1182/blood-2018-99-116477

Published: 2018

Journal Articles

HLA-a*0101 Expression Correlates with Increased Risk of Severe Cutaneous Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Maira Fonseca, MD, Ann A. Jakubowski, MD PhD, Sean M Devlin, PhD, James W. Young, MD, Samira A Fatmi, BS, Molly Maloy, MS, Sergio Giralt, MD, Doris Ponce, MD, Alina Markova, MD

Blood (2018) 132 (Supplement 1): 4564.

https://doi.org/10.1182/blood-2018-99-110405

Published: 2018

Journal Articles

Rash in Patients after T-Cell-Depleted Peripheral Blood Stem Cell Transplantation: Eosinophilia and Pruritus Do Not Distinguish Acute Graft-Versus-Host Disease from Drug Rash

Skylar A Klager, MS, Sean M Devlin, PhD, Margaret Hannum, MS, Ann A. Jakubowski, MD PhD, Alina Markova, MD

Blood (2018) 132 (Supplement 1): 4570.

https://doi.org/10.1182/blood-2018-99-110307

Published: 2018

Journal Articles

CD34+Selected Hematopoietic Stem Cell Transplants Conditioned with a Myeloablative Regimen Is Well Tolerated and Results in Good Outcomes in Patients with Myelofibrosis

Jeong-Ok Lee, MD, Jessica Flynn, BS, Molly Maloy, MS, Ann A. Jakubowski, MD PhD, Esperanza B. Papadopoulos, MD, Christina Cho, MD, Doris Ponce, MD, Craig S. Sauter, MD, Miguel-Angel Perales, MD, Sean M Devlin, PhD, Sergio Giralt, MD, Hugo R. Castro-Malaspina, MD, Roni Tamari, MD

Blood (2018) 132 (Supplement 1): 4636.

https://doi.org/10.1182/blood-2018-99-113166

Published: 2018

Journal Articles

Late Effects of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT) in Elderly Patients with Lymphoma

Parastoo B. Dahi, MD, Chikaodi Obioha, Sheila Kenny, NP, Patrick Hilden, MS, Molly Maloy, MS, Alexander Geyer, MD, Wendy Schaffer, MD, Roni Tamari, MD, Craig S. Sauter, MD, Ann A. Jakubowski, MD PhD, Sergio Giralt, MD

Blood (2018) 132 (Supplement 1): 4620.

https://doi.org/10.1182/blood-2018-99-112632

Published: 2018

Journal Articles

Allogeneic Stem Cell Transplantation Overcomes the Negative Prognostic Impact of TP53 Alterations in Mantle Cell Lymphoma

Richard J Lin, MDPhD, Caleb Ho, MD, Patrick Hilden, MS, Juliet Barker, MBBS, Sergio Giralt, MD, Paul A. Hamlin, MD, Ann A. Jakubowski, MDPhD, H.R. Castro-Malaspina, MD, Esperanza B. Papadopoulos, MD, Miguel-Angel Perales, MD, Craig S. Sauter, MD

Blood (2018) 132 (Supplement 1): 4668.

https://doi.org/10.1182/blood-2018-99-113186

Published: 2018

Journal Articles

Double-Unit Cord Blood (CB) Transplantation with Haplo-Identical CD34+ Cells (haplo-dCBT) May Speed Neutrophil Recovery Although Successful Bridging Is Contingent on Close Haplo-Winning CB Unit HLA-Match

Blood (2018) 132 (Supplement 1): 2078.

https://doi.org/10.1182/blood-2018-99-116276

Published: 2018

Journal Articles

Burden and Impact of Geriatric Syndromes Associated with Allogeneic Hematopoietic Cell Transplantation in Older Adults

Richard J Lin, MD PhD, Theresa A Elko, MS, Patrick Hilden, MS, Parastoo B. Dahi, MD, Ann A. Jakubowski, MD PhD, Miguel-Angel Perales, MD, Juliet Barker, MBBS, H.R. Castro-Malaspina, MD, Brian C. Shaffer, MD, Armin Shahrokni, MD, Roni Tamari, MD, Esperanza B. Papadopoulos, MD, Craig S. Sauter, MD, Molly Maloy, MS, Beatriz Korc-Grodzicki, MD PhD, Sergio Giralt, MD

Blood (2018) 132 (Supplement 1): 3370.

https://doi.org/10.1182/blood-2018-99-113876

Published: 2018

Journal Articles

A Simple Geriatric Vulnerability Index for Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

Richard J Lin, MD PhD, Theresa A Elko, MS, Sean M Devlin, PhD, Ann A. Jakubowski, MD PhD, Armin Shahrokni, MD, Parastoo B. Dahi, MD, Miguel-Angel Perales, MD, Roni Tamari, MD, Brian C. Shaffer, MD, Craig S. Sauter, MD, Esperanza B. Papadopoulos, MD, H.R. Castro-Malaspina, MD, Juliet Barker, MBBS, Molly Maloy, MS, Beatriz Korc-Grodzicki, MD PhD, Sergio Giralt, MD

Blood (2018) 132 (Supplement 1): 2176.

https://doi.org/10.1182/blood-2018-99-113688

Published: 2018

Journal Articles

Ex Vivo T Cell-Depleted and In Vivo T Cell-Depleted Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in First Complete Remission Resulted in Similar Overall Survival Survival: On Behalf of the ALWP of the EBMT and the MSKCC

Florent Malard, MDPhD, Myriam Labopin, MD PhD, Christina Cho, MD, Didier Blaise, Esperanza B. Papadopoulos, MD, Jakob R. Passweg, MDMS, Richard O'Reilly, MD, Noel Milpied, Molly Maloy, MS, Liisa Volin, H.R. Castro-Malaspina, MD, Yosr Hicheri, Ann A. Jakubowski, MD PhD, Sylvie François, Sergio A. Giralt, MD, Mohamad Mohty, MD PhD, Arnon Nagler, MD, Miguel-Angel Perales, MD

Blood (2017) 130 (Supplement 1): 4564.

https://doi.org/10.1182/blood.V130.Suppl_1.4564.4564

Published: 2017

Journal Articles

Candidate Gene Associations with Vaso-Occlusive Crisis in Children with Sickle Cell Anemia Enrolled in the Multinational DOVE Trial

Carolyn C Hoppe, MD, Joseph A Jakubowski, PhD, Wendra M Foster, Lori E Heath, Sreekumar Pillai, Bhatnagar Pallav

Blood (2017) 130 (Supplement 1): 962.

https://doi.org/10.1182/blood.V130.Suppl_1.962.962

Published: 2017

Journal Articles

Long-Term Follow-up of Adult Double Unit Cord Blood (CB) Transplantation (dCBT) Recipients Reveals High Rates of Progression-Free Survival after a Novel Cy/ Flu/ Thio/ TBI 400 Intermediate Intensity Conditioning Regimen

Blood (2017) 130 (Supplement 1): 4589.

https://doi.org/10.1182/blood.V130.Suppl_1.4589.4589

Published: 2017

Journal Articles

CMV Reactivation Post CD34+ Selected Allo-HCT Has Adverse Outcomes on Blood Counts Recovery

Roni Tamari, MD, Christina Cho, MD, Patrick Hilden, MS, Taylor Borrill, BA, CCRP, Molly Maloy, MS, H.R. Castro-Malaspina, MD, Esperanza B. Papadopoulos, MD, Ann A. Jakubowski, MD PhD, Genovefa Papanicolaou, Sergio A. Giralt, MD, Miguel-Angel Perales, MD

Blood (2017) 130 (Supplement 1): 3319.

https://doi.org/10.1182/blood.V130.Suppl_1.3319.3319

Published: 2017

NARROW

High Progression-Free Survival with Low Relapse Rates after Double-Unit Cord Blood Transplantation in Patients with High-Risk AML

Optimized Double-Unit Cord Blood Transplantation Mitigates Transplant-Related Mortality Resulting in High Progression-Free Survival in Adults with Hematologic Malignancies

Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Leukemia

Prospective Analysis to Determine Barriers to Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed and Relapsed Acute Leukemia

Racial Disparities in Access to Alternative Donor Allografts Persist in the Era of "Donors for All"

Clinical Outcomes of Acute Myeloid Leukemia Patients Bridged to Allogeneic Stem Cell Transplant By Venetoclax Combination Therapy

Rabbit Anti-Thymocyte Globulin Exposure (rATG) in CD34+ Selected Hematopoietic Cell Transplantation and Its Impact on Immune Reconstitution and Outcomes in Children and Adults

A High Degree of Engrafting Unit-Recipient HLA-Allele Mismatch Is Not Associated with an Increased Risk of Transplant-Related Mortality (TRM) or Inferior Progression-Free Survival (PFS) after Double Unit Cord Blood (CB) Transplantation (dCBT) in Adults with Hematologic Malignancies

HLA-a*0101 Expression Correlates with Increased Risk of Severe Cutaneous Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Rash in Patients after T-Cell-Depleted Peripheral Blood Stem Cell Transplantation: Eosinophilia and Pruritus Do Not Distinguish Acute Graft-Versus-Host Disease from Drug Rash

CD34+Selected Hematopoietic Stem Cell Transplants Conditioned with a Myeloablative Regimen Is Well Tolerated and Results in Good Outcomes in Patients with Myelofibrosis

Late Effects of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT) in Elderly Patients with Lymphoma

Allogeneic Stem Cell Transplantation Overcomes the Negative Prognostic Impact of TP53 Alterations in Mantle Cell Lymphoma

Double-Unit Cord Blood (CB) Transplantation with Haplo-Identical CD34+ Cells (haplo-dCBT) May Speed Neutrophil Recovery Although Successful Bridging Is Contingent on Close Haplo-Winning CB Unit HLA-Match

Burden and Impact of Geriatric Syndromes Associated with Allogeneic Hematopoietic Cell Transplantation in Older Adults

A Simple Geriatric Vulnerability Index for Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

Ex Vivo T Cell-Depleted and In Vivo T Cell-Depleted Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in First Complete Remission Resulted in Similar Overall Survival Survival: On Behalf of the ALWP of the EBMT and the MSKCC

Candidate Gene Associations with Vaso-Occlusive Crisis in Children with Sickle Cell Anemia Enrolled in the Multinational DOVE Trial

Long-Term Follow-up of Adult Double Unit Cord Blood (CB) Transplantation (dCBT) Recipients Reveals High Rates of Progression-Free Survival after a Novel Cy/ Flu/ Thio/ TBI 400 Intermediate Intensity Conditioning Regimen

CMV Reactivation Post CD34+ Selected Allo-HCT Has Adverse Outcomes on Blood Counts Recovery

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only